logo
episode-header-image
Jun 2024
5m 48s

Tasty Morsels of Critical Care 082 | Car...

Andy Neill
About this episode

Welcome back to the tasty morsels of critical care podcast.

We’re going to cover a bit of an environmental/tox topic today and look at carbon monoxide poisoning from Oh’s manual chapter 83 on burns. I have previously covered this on the old tasty morsels of EM series back when i was doing my EM fellowship exams.

As you no doubt remember from school chemistry classes, carbon monoxide is a colourless, odourless, tasteless gas produced when combustion occurs with insufficient oxygen.

We’re likely to see this in a couple of contexts.

1) the house fire victim, pulled from the fire unconscious and sick

2) the sub acute or chronic poisoning in a patient presenting with headaches and flu symptoms that seem to get better when they leave the problem environment. The classic EM example is the whole family who present with flu symptoms and no fever and even the dog is sick. We’re much less likely to see this cohort in the critical care side of things.

How does it make people sick? Haemoglobin is a fickle little protein, while evolved to carry oxygen to needy tissue beds it actually has a distinct preference not for our beloved oxygen but for carbon monoxide. Introduce some carbon monoxide at the alveolus and the haemoglobin molecule will bind to CO with an affinity 240 times that than for oxygen. I take that number of 240 somewhat at face value but I presume someone got a PhD from working that out. In visual form my preferred means of explanation for this would be the distracted boyfriend meme where the haemoglobin boyfriend looks longingly over his shoulder at the carobon monoxide while his oxygen girlfriend looks on in horror. Hopefully you get the idea.

So instead of having lots of circulating oxyhaemoglobin we’re instead left with lots of not especially useful carboxyhaemoglobin. Let’s imagine 50% of our Hb is now carboxyHb and 50% is OxyHb we’re left with a sort of severe fucntional anaemia where half of our Hb is out of action. One might be inclined to think that this is the major cause of morbidity and mortality in CO poisoning but in fact this is only a small portion of the problem. CoHb actually has a direct cytotoxic effect on things cytochrome oxidase and myoglobin function. As such it interrupts the whole process of oxidative metabolism and life as we know it.

We can measure the level of CO fairly easily, any blood gas machine worth its salt should be able to give you a break down of the types of Hb present in the sample. This is co-oximetry and typically it’ll show you oxy, deoxy, carboxy and met haemoglobins. All these different forms of Hb absorb different wavelengths of light. The lowly pulse oximeter does not have the subtlety to distinguish the different wavelengths as it only functions at wavelengths of 940 and 660nm. Indeed the pulse ox often demonstrates a non diagnostic number somewhere in the 80s rather than a true reflection of the CarboxyHb or OxyHb present.

Severe CO poisoning resulting in obtundation is going to have high level of COHb on our cooximeter. >10% is quoted but it’s more often over 30%. Patients are going to be pretty sick often from multiple pathologies but COHb on its own is enough to produce severe neurological injury, shock and even cardiac injury is also quite prevalent. Expect a high lactate given the disruption of oxidative metabolism. Resuscitate and investigate as you would any sick patient.

Treatment is nice and simple in that we just give loads of oxygen. Oxygen reduces the half life of CO in the blood quite dramatically, commonly quoted numbers are

  • the haf-life of COHb in an FiO2 of 0.21 is 300 minutes
  • the half-life of COHb in an FiO2 of 1.0 is 60-90 minutes 

There is a substantial rationale and literature on the use of hyperbaric oxygen as a means of accelerated clearance of COHb. But the RCTs that have been done don’t seem (to me at least) to give a clear benefit. The Lindell Weaver NEJM RCT in 2002 did suggest a neuro benefit but only 8% of the patients in this trial were intubated. A follow up trial in 2011 by ICU steroid guru Djilalli Annane did not find a benefit . So if anyone should get this it might be the non intubated isolated COHb poisoining. This is not really our cohort. Our cohort is likely to be tubed, shocked, with multiple injuruies and not someone you want to transport cross county to put in a single person hyperbaric chamber for hours at a time.

Reading

Oh Manual Chapter 83

Weaver, L. K. et al. Hyperbaric oxygen for acute carbon monoxide poisoning. The New England journal of medicine 347, 1057–1067 (2002).
Annane, D. et al. Hyperbaric oxygen therapy for acute domestic carbon monoxide poisoning: two randomized controlled trials. Intensive Care Medicine 37, 486–492 (2011).

 

 

 

Up next
Nov 24
Tasty Morsels of Critical Care 091 | Pulmonary Embolism Management
<p>Welcome back to the <a href="https://emergencymedicineireland.com/the-tasty-morsels">tasty morsels of critical care podcast</a>.</p> <p>This is the second of 2 parts on PE in critical care. The first focused on risk stratification and this one will focus on management. There i ... Show More
10m 59s
Nov 10
Tasty Morsels of Critical Care 090 | Pulmonary Embolism Risk Stratification
<p>Welcome back to the <a href="https://emergencymedicineireland.com/the-tasty-morsels">tasty morsels of critical care podcast</a>.</p> <p>I haven&#8217;t managed to cover PE on the podcast yet. I have been involved in lots of small PE projects over the years and have developed s ... Show More
8m 3s
Sep 29
Tasty Morsels of Critical Care 089 | Hypertriglyceridemia-induced acute pancreatitis
<p>Welcome back to the <a href="https://emergencymedicineireland.com/the-tasty-morsels">tasty morsels of critical care podcast</a>.</p> <p>Hypertriglyceridaemua induced pancreatitis came up at a recent trainee presentation and I thought despite it being pretty niche and rare, it& ... Show More
4m 32s
Recommended Episodes
Mar 2022
Episode 009: Cytopenias Series Pt. 1 - Thrombocytopenia
<p class="" style="white-space:pre-wrap;">One of our most common consults in hematology is teams seeking guidance for workup and management of thrombocytopenia. In this episode, we cover our approach to this hematologic conundrum. </p><p class="" style="white-space:pre-wrap;">Ma ... Show More
27m 24s
Mar 2025
414. Case Report: Got Milky Blood? Hypertriglyceridemia Unveiled in a Case of Abdominal Pain – National Lipid Association
CardioNerds co-founders Dr. Daniel Ambinder and Dr. Amit Goyal are joined by Dr. Spencer Weintraub, Chief Resident of Internal Medicine at Northwell Health, Dr. Michael Albosta, third-year Internal Medicine resident at the University of Miami, and Anna Biggins, Registered Dietiti ... Show More
1h 17m
Jan 2025
Review of the Primary Angioplasty in Myocardial Infarction Study Group trial
N Engl J Med 1993;328:673-679Background: Previous trials established that thrombolysis improves mortality in patients with acute myocardial infarction, as seen in the GISSI-1 and ISIS-2 trials. However, thrombolysis has limitations, including an increased risk of bleeding and the ... Show More
12m 26s
Feb 2025
410. Case Report: A Curious Case of Refractory Ventricular Tachycardia – Rutgers-Robert Wood Johnson
CardioNerds (Dr. Colin Blumenthal and Dr. Saahil Jumkhawala) join Dr. Rohan Ganti, Dr. Nikita Mishra, and Dr. Jorge Naranjo from the Rutgers – Robert Wood Johnson program for a college basketball game, as the buzz around campus is high. They discuss the following case involving a ... Show More
40m 13s
Apr 2024
Episode 899: Thrombolytic Contraindications
<p dir="ltr"><strong>Contributor: Travis Barlock MD</strong></p> <p dir="ltr"><strong>Educational Pearls:</strong></p> <ul> <li dir="ltr" aria-level="1"> <p dir="ltr" role="presentation">Thrombolytic therapy (tPA or TNK) is often used in the ED for strokes</p> </li> <li dir="ltr" ... Show More
3m 51s
May 2025
Episode 209: Blast Crisis
<div class="row"> <div class="col-sm-4"> <a href="https://coreem.net/podcast/episode-209-blast-crisis/" title="Episode 209: Blast Crisis" rel="bookmark"> <img width="576" height="576" src="https://coreem.net/content/uploads/2025/04/Blast-Crisis.001.j ... Show More
10m 15s
Dec 2024
Episode 936: Etomidate vs. Ketamine for Rapid Sequence Intubation
<p dir="ltr"><strong>Contributor: Ricky Dhaliwal MD</strong></p> <p dir="ltr"><strong>Educational Pearls: </strong></p> <ul> <li dir="ltr" aria-level="1"> <p dir="ltr" role="presentation">Etomidate was previously the drug of choice for rapid sequence intubation (RSI)</p> </li> <u ... Show More
4m 58s
Feb 2024
Myocarditis
<p>Myocarditis is the inflammation of the heart muscle. This muscle is the middle layer of the heart, formally called the myocardium, hence the name myocarditis (the -itis suffix indicates inflammation). Inflammation of the myocardium can be caused by a variety of etiologies, fro ... Show More
21m 42s
Jan 2025
Episode 204: Necrotizing Fasciitis
<div class="row"> <div class="col-sm-4"> <a href="https://coreem.net/podcast/episode-204-necrotizing-fasciitis/" title="Episode 204: Necrotizing Fasciitis" rel="bookmark"> <img width="576" height="576" src="https://coreem.net/content/uploads/2025/01/ ... Show More
9m 12s
Jun 2025
Clopidogrel Versus Aspirin For Long-term Maintenance Monotherapy In Patients With High Ischemic Risk After PCI
The SMART-CHOICE 3 trial demonstrated that clopidogrel monotherapy is more effective than aspirin monotherapy in reducing the risk of major adverse cardiac and cerebrovascular events in high-risk patients who completed standard dual antiplatelet therapy (DAPT) following percutane ... Show More
9m 15s